Skip to content
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Investigator Initiated
Research
Contact Us
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Investigator Initiated
Research
Contact Us
Search
Back to News
February 6, 2017
Endologix Announces Appointment of Dan Lemaitre as Chairman of the Board John McDermott to Continue as Chief Executive Officer
Prev
Previous
Positive Three-Year Results from the Ovation® European Post Market Registry Presented at 2017 LINC Symposium
Next
Endologix Completes Patient Enrollment in the Ovation(R) LUCY Study First Prospective Study Evaluating EVAR in a Female Population
Next
